NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 52 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | +28.6% | 64,995 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -53.3% | 64,995 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | -16.7% | 64,995 | -15.0% | 0.00% | – |
| Q2 2018 | $18,000 | -33.3% | 76,460 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | 0.0% | 76,460 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | -15.6% | 76,460 | -0.9% | 0.00% | – |
| Q3 2017 | $32,000 | -20.0% | 77,160 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | -11.1% | 77,160 | 0.0% | 0.00% | – |
| Q1 2017 | $45,000 | -8.2% | 77,160 | 0.0% | 0.00% | – |
| Q4 2016 | $49,000 | -31.0% | 77,160 | 0.0% | 0.00% | – |
| Q3 2016 | $71,000 | +73.2% | 77,160 | 0.0% | 0.00% | – |
| Q2 2016 | $41,000 | -97.9% | 77,160 | -96.3% | 0.00% | – |
| Q1 2016 | $1,970,000 | -29.4% | 2,086,876 | -0.5% | 0.00% | – |
| Q4 2015 | $2,789,000 | -41.2% | 2,097,966 | +0.8% | 0.00% | -100.0% |
| Q3 2015 | $4,745,000 | +41.5% | 2,081,638 | -0.1% | 0.00% | – |
| Q2 2015 | $3,353,000 | +3.0% | 2,083,684 | +1.7% | 0.00% | – |
| Q1 2015 | $3,256,000 | -9.7% | 2,047,989 | +7.3% | 0.00% | – |
| Q4 2014 | $3,606,000 | +43.2% | 1,907,774 | -0.1% | 0.00% | – |
| Q3 2014 | $2,518,000 | -7.8% | 1,908,761 | +3.5% | 0.00% | – |
| Q2 2014 | $2,730,000 | -20.5% | 1,844,058 | -0.6% | 0.00% | – |
| Q1 2014 | $3,432,000 | -56.0% | 1,854,788 | -42.5% | 0.00% | – |
| Q4 2013 | $7,792,000 | +68.9% | 3,223,992 | +85.3% | 0.00% | -100.0% |
| Q3 2013 | $4,614,000 | +7.2% | 1,739,628 | +7.9% | 0.00% | 0.0% |
| Q2 2013 | $4,306,000 | – | 1,612,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|